These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4911758)

  • 41. Demonstrating drug action.
    Tamminga CA
    Am J Psychiatry; 2004 Jun; 161(6):943-5. PubMed ID: 15169679
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical experimentation today: a historic turning-point for the medical profession].
    Selvini A
    G Ital Cardiol; 1985 Jun; 15(6):611-4. PubMed ID: 3905487
    [No Abstract]   [Full Text] [Related]  

  • 43. ICH harmonized tripartite guideline: Guideline for Good Clinical Practice.
    International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use.
    J Postgrad Med; 2001; 47(1):45-50. PubMed ID: 11590294
    [No Abstract]   [Full Text] [Related]  

  • 44. Should it be easier or harder to use unapproved drugs and devices?
    Flannery EJ
    Hastings Cent Rep; 1986 Feb; 16(1):17-23. PubMed ID: 3514546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical therapeutic trials].
    Mathé G
    Bull Cancer; 1974; 61(2):191-212. PubMed ID: 4619025
    [No Abstract]   [Full Text] [Related]  

  • 46. [The lesson of the practolol drama; can adverse effects of drugs be recognized as such sooner?].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1978 Nov; 122(44):1709-12. PubMed ID: 360080
    [No Abstract]   [Full Text] [Related]  

  • 47. Subgroup analyses in clinical trials.
    Kent D; Hayward R
    N Engl J Med; 2008 Mar; 358(11):1199; author reply 1199-200. PubMed ID: 18340666
    [No Abstract]   [Full Text] [Related]  

  • 48. [Sequential statistical trials in medicine].
    Winne D
    Arzneimittelforschung; 1965 Sep; 15(9):1088-91. PubMed ID: 5324712
    [No Abstract]   [Full Text] [Related]  

  • 49. The use of statistics in the ANZ Journal of Surgery.
    Dent O; Hall JC
    ANZ J Surg; 2010 Mar; 80(3):121-2. PubMed ID: 20575907
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pharmacotherapy between theory and practice].
    Stricker BH
    Ned Tijdschr Geneeskd; 1995 Nov; 139(45):2295-6. PubMed ID: 7501059
    [No Abstract]   [Full Text] [Related]  

  • 51. Pregnancy and pills. New research finds prescriptions may be safer than you think.
    Schultz S
    US News World Rep; 1999 Apr; 126(13):64-6. PubMed ID: 10351523
    [No Abstract]   [Full Text] [Related]  

  • 52. Statement on matching language to the type of evidence used in describing outcomes data.
    HEART Group Journals
    J Am Soc Echocardiogr; 2012 Dec; 25(12):1353. PubMed ID: 23200419
    [No Abstract]   [Full Text] [Related]  

  • 53. [Introduction to the problems of clinical pharmacological research].
    Rahlfs VW
    Int J Clin Pharmacol; 1972 Nov; 6(4):385-90. PubMed ID: 4565837
    [No Abstract]   [Full Text] [Related]  

  • 54. Editorial: Historical controls reincarnated: an examination of techniques for clinical therapeutic research.
    Freireich EJ; Gehan EA
    Cancer Chemother Rep; 1974; 58(5 Pt 1):623-6. PubMed ID: 4609596
    [No Abstract]   [Full Text] [Related]  

  • 55. Statistical proof in inconclusive 'negative' trials.
    Reed JF; Slaichert W
    Arch Intern Med; 1981 Sep; 141(10):1307-10. PubMed ID: 7271405
    [No Abstract]   [Full Text] [Related]  

  • 56. Expanding the perspective of translational medicine: the value of observational data.
    Liebman MN; Marincola FM
    J Transl Med; 2012 Mar; 10():61. PubMed ID: 22452969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Statistics for clinicians. 6. Comparing two samples (the two-sample t test).
    O'Brien PC; Shampo MA
    Mayo Clin Proc; 1981 Jun; 56(6):393-4. PubMed ID: 7015029
    [No Abstract]   [Full Text] [Related]  

  • 58. [Bases for planning and conducting clinical experiments].
    Immich H
    Med Welt; 1969 Jul; 27():1517-21. PubMed ID: 4895203
    [No Abstract]   [Full Text] [Related]  

  • 59. [What does a 50 percent reduction of risk mean? Results from clinical trials are often misleading].
    Enkvist C; Werkö L
    Lakartidningen; 1994 Mar; 91(11):1091-2. PubMed ID: 8139338
    [No Abstract]   [Full Text] [Related]  

  • 60. Newborns still lack drug data to guide therapy.
    Ward RM; Sherwin CM
    Br J Clin Pharmacol; 2016 Dec; 82(6):1410-1411. PubMed ID: 27696484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.